miR-542-3p prevents ovariectomy-induced osteoporosis in rats via targeting SFRP1

Area of Science:

• Molecular Biology
• Bone Biology
• Signaling Pathways

Background:

• Secreted frizzled-related protein-1 (SFRP1) negatively regulates WNT signaling and is a therapeutic target for bone formation.
• Osteoporosis, particularly postmenopausal osteoporosis, is characterized by impaired bone formation.
• MicroRNAs (miRNAs) are key regulators of gene expression with potential roles in bone metabolism.

Purpose of the Study:

• To investigate the role of miR-542-3p in bone formation and its relationship with SFRP1 in osteoporosis.
• To elucidate the mechanism by which miR-542-3p influences osteoblast differentiation and bone metabolism.

Main Methods:

• Established an ovariectomized (OVX) rat model to simulate postmenopausal osteoporosis.
• Utilized RNA sequencing, qRT-PCR, luciferase reporter assays, and Western blotting to analyze gene and protein expression.
• Investigated the effect of miR-542-3p on mesenchymal stem cell (MSC) differentiation and bone formation in vivo.

Main Results:

• Downregulation of miR-542-3p and upregulation of SFRP1 were observed in OVX rats and postmenopausal women with osteoporosis.
• miR-542-3p directly inhibits SFRP1 expression at both mRNA and protein levels.
• miR-542-3p promotes osteoblast differentiation and enhances bone formation in vivo.

Conclusions:

• miR-542-3p plays a critical role in bone formation by suppressing SFRP1 and promoting osteoblast differentiation.
• The miR-542-3p/SFRP1 axis represents a potential therapeutic strategy for treating osteoporosis.